Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Research from Fourth Military Medical University, State Key Laboratory of Cancer Biology and Institute of Digestive Disease yields new findings on cancer gene therapy
October 14th, 2008
A new study, 'The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells,' is now available. "p75 neurotrophin receptor (p75NTR), a member of the TNF receptor superfamily, is a focus for study at present. Up to now, its role and functions in hepatocellular carcinoma were not fully elucidated," investigators in People's Republic of China report. "In this study, we investigated the expression of p75NTR in hepatocellular carcinoma and the impact of its alteration on tumor growth. We found that the expression of p75NTR was decreased significantly in 158 cases of hepatocellular carcinoma tissues as compared with their adjacent...
Source: Cancer Weekly (2008-10-14)
|
